CN Patent

CN103588762A — 坎格列净的新晶型及其制备方法

Assigned to Crystal Pharmatech Co Ltd · Expires 2014-02-19 · 12y expired

What this patent protects

本发明涉及1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯的新晶型。本发明也提供了1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯新晶型的制备方法。

USPTO Abstract

本发明涉及1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯的新晶型。本发明也提供了1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯新晶型的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103588762A
Jurisdiction
CN
Classification
—
Expires
2014-02-19
Drug substance claim
No
Drug product claim
No
Assignee
Crystal Pharmatech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.